000 01178 a2200325 4500
005 20250514070911.0
264 0 _c20030612
008 200306s 0 0 eng d
022 _a0098-7484
024 7 _a10.1001/jama.289.21.2865
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLauner, Lenore J
245 0 0 _aNonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
_h[electronic resource]
260 _bJAMA
_cJun 2003
300 _a2865-7 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xtherapeutic use
650 0 4 _aBrain
_xdrug effects
650 0 4 _aCyclooxygenase 1
650 0 4 _aCyclooxygenase 2
650 0 4 _aCyclooxygenase 2 Inhibitors
650 0 4 _aCyclooxygenase Inhibitors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aMembrane Proteins
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xmetabolism
773 0 _tJAMA
_gvol. 289
_gno. 21
_gp. 2865-7
856 4 0 _uhttps://doi.org/10.1001/jama.289.21.2865
_zAvailable from publisher's website
999 _c12569481
_d12569481